Dava Stewart

These signal voids could help clinicians more specifically identify AMD in patients.

Early success of the DANA allows for more frequent cognitive testing in patients with major depressive disorder.

This development can have future implications for patients with age-related macular degeneration.

Interaction between early-life stress and FKBP5 gene variants link to major depressive disorder and post-traumatic stress disorder.

Researchers believe that metabolomic profiling could deepen the understanding of how lipids function in the pathogenesis of AMD

Previous studies have reported that between 75% and 84% of MMT patients report sleep difficulties, and the 71% of those receiving buprenorphine in the current study is comparable.

Researchers found two loci, TRPM1 and ABHD2/RLBP1, with previously unrecognized associations related to the risk of age-related macular degeneration.

The researchers noted that the majority of research has focused on hormonal differences, despite significant differences in immune function between the sexes.

A flexible Bayesian variable selection model was crafted for accounting for functional annotations of genetic variants for identifying risk signals.

While the causes of MDD and bipolar disorder are unknown, there are clues that genetics play a role.

The study identified the CYP-derived lipid biometabolites and determined that they help reduce inflammation within CNV lesions.

Researchers investigated the association between D2 and D3 receptor availability in the striatum and cognitive function in adults with major depressive disorder.

Using 24-hour wrist monitors, the study revealed “distinct mood-dependent effects on wrist-activity markers of circadian timekeeping.”

The genome wide association study found that a there may be a genetic link to how depression treatments work.

A review of non-pharmacological options for treating MDD found that there was not enough evidence to support their use.

Ten patients to undergo the transplant were treated with direct-acting antiviral Zepatier for 12 weeks post-op.

A web-based weight loss intervention may be a potential avenue for obesity management in patients with T2D.

The method has been commonly used to identify rare drug-resistant variants of the HIV virus.

Patients with T1D should be screened for depression and diabetes-related distress.

The drugs proved to be less costly than living without treatment, while also improving patients' life expectancies.

Being able to view the cellular-level mechancial changes could allow doctors to sooner gauge how direct-acting antivirals are treating — or failing to treat — HCV.

Researchers are working to identify T1D patients earlier, prevent mishaps before they occur.

So-called “divided dinners” are a practical strategy for people with T2D.

Swedish researchers have answered a big question about the pre-diabetic period.

A review of Initial presentation and management of acute myocardial infarction.

Study results also showed that levosimendan did not positively affect secondary outcome measures compared to placebo.

Results of a new study indicate an unrecognized systolic dysfunction.

A German study examined the intestinal microbiomes of 20 HF patients.

Treating systolic blood pressure of >120 mmHG reduces risk of acute decompensated heart failure.

Wheezing from RV in the first 3 years of life leads to higher risk of asthma.